Viking Therapeutics Inc. | Key People and Executives
Brian Lian
President, Chief Executive Officer & Director
Matthew W. Foehr
Director
Lawson Macartney
Chairman
Charles A. Rowland
Independent Director
Stephen W. Webster
Independent Director
J. Matthew Singleton
Independent Director
Brian Lian
President, Chief Executive Officer & Director
Gregory S. Zante
Vice President-Operations & Finance
Michael Morneau
CFO & Principal Accounting Officer
Marianne Mancini
Senior Vice President-Clinical Operations
Amy Broidrick
Senior Vice President-Corporate Development
Matthew W. Foehr
Director
Stephanie Diaz
Investor Relations Contact
Lawson Macartney
Chairman
Charles A. Rowland
Independent Director
Stephen W. Webster
Independent Director
J. Matthew Singleton
Independent Director
| Address |
12340 El Camino Real
San Diego California 92130
United States
|
|
Employees
|
- |
| Website |
http://www.vikingtherapeutics.com |
| Updated |
07/08/2019 |
| Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. Its clinical program VK5211, treats patients recovering from non-elective hip fracture surgery. It also specializes in development of VK2809 and VK0214. |
